期刊文献+

两种结合雌激素对改善绝经期综合征的临床观察 被引量:3

Clinical observation of two kinds of conjugated estrogen in the treatment of menopausal symptoms
下载PDF
导出
摘要 目的:观察比较结合雌激素片(试验组)与结合雌激素倍美力片(对照组)治疗绝经期综合征的疗效和安全性。方法:选取60例符合诊疗标准的患者随机分成试验组和对照组,每日服结合试验或对照药物1片,28天为1周期,第15~28天均添加安宫黄体酮片每日4mg,通过随机开放平行对照方法对两组潮热症状评分,Kupperman评分、血清E2水平、血脂的变化及不良反应发生情况比较。结果:两组治疗后,潮热症状评分及Kupperman评分均明显下降,血清雌二醇、甘油三酯(TG)和高密度脂蛋白(HDL-C)均升高,低密度脂蛋白(LDL-C)降低,组内比较(P<0.001),差异有统计学意义。组间等效性检验比较(P>0.05),无显著性差异。不良反应两组之间比较(P>0.05),无显著差异。结论:国产结合雌激素片和倍美力一样能有效、安全地治疗妇女绝经期综合征。 Objective:To compare the efficacy and the safety of conjugated estrogen(CE) in the treatment of menopausal with conjugated equine estrogen(Premarin). Methods:According to the standards ,a total of 60 patients were randomly divided into 2 groups:CE group and Premarin group,a period of 28 days,and from 15 to 28 days plus medroxyprogesterone(MPA) 4 mg Daily.Treatment lasted for 3 periods. This randomly publicly parallel was adopted to compare the hot flashes symptom scores,serum level of estradiol,Kupperman measurement Index and serum lipid. Results:The scores of menopausal symptom,hot flash scores and the serum level of estradiol ascent. TG、HDL-C ascented and LDL-C were reduced after treatment with CE or Premarin(P 〈 0.001),No significant differences were discovered between the two groups through equivalence margin(P 〉 0.05). There are no significant differences between the two groups on side effect(P 〉 0.05). Conclusion:CE is safe and effective in treatment of menopausal symptoms.
出处 《南京医科大学学报(自然科学版)》 CAS CSCD 北大核心 2007年第9期989-991,1004,共4页 Journal of Nanjing Medical University(Natural Sciences)
基金 江苏省高校自然科学研究基金资助(05KJB320087)
关键词 结合雌激素 倍美力 绝经期综合征 conjugated estrogen Premarin menopausal symptoms
  • 相关文献

参考文献9

二级参考文献24

  • 1任芸芸,朱关珍.孕激素对绝经后妇女骨质代谢的影响[J].中华妇产科杂志,1995,30(3):135-137. 被引量:9
  • 2林蓓,李春桃,陈桂兰,魏军,刘伟,郭津津,王富伟,王继东,崔波.妊高征患者血清载脂蛋白及脂蛋白(a)含量的测定[J].中华妇产科杂志,1995,30(7):417-418. 被引量:16
  • 3武须军,尹永洗.脂蛋白(a)研究概况[J].国外医学(临床生物化学与检验学分册),1989,10(3):16-19. 被引量:2
  • 4卫生部继续医学教育委员会.女性生殖内分泌性激素补充疗法[M].北京:北京医科大学、中国协和医科大学联合出版社,1999.84-90.
  • 5[1]Tepper R,Pardo J,Ovadia J,et al.Menopausal hot flushes, plasma calcitonin and beta-endorphin.Gynecol Obstet Invest,1992,33:98
  • 6[2]Recker RR.The effect of low-dose continuous estrogen and progesterone therapy with calcium and vitamin D on bone in elderly women;a randomized,controlled trial.Ann Intern Med,1999,130:897
  • 7[3]Women's Health Initiative Randomized Controlled Trial.Risk and benefits of estrogen progestin in healthy postmenopausal women.JAMA,2002,283(3):321
  • 8[4]Speroff L. Postmenopausal homorne therapy and primary prevention of cardiovascular disease-Nurses' health study 20-year follow-up.Maturitas,2001,38:221
  • 9[5]Hulley S,Grady D.Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS)Research Group. J Am Med Assoc,1998,280:605
  • 10[6]Grodstein F,Mcrtinez ME.Postmenopausal hormone use and risk for colorectal cancer and adenoma. Ann Intern Med,1998,128:705

共引文献55

同被引文献45

引证文献3

二级引证文献37

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部